We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Declan McCole PhD

Declan F. McCole PhD

Professor of Biomedical Sciences, Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California

Dr. McCole obtained his Ph.D. from the Department of Pharmacology and the Faculty of Veterinary Medicine, University College Dublin, Ireland in 1997. He conducted postdoctoral research at the University of California, San Diego prior to obtaining a junior faculty appointment as a Project Scientist in 2004 and as an Assistant Professor of Medicine in 2009. In 2013 he was recruited from UCSD to join the new School of Medicine (SOM) at the University of California, Riverside. In 2015 he was promoted to Associate Professor with Tenure, and in 2019 to Full Professor, at UCR.

His research focuses on regulation of intestinal epithelial barrier function in inflammatory bowel disease (IBD). His lab was the first to identify that the IBD candidate gene, PTPN2, protects intestinal epithelial barrier function from the effects of inflammation. In addition to researching potential therapies to enhance intestinal barrier function, his lab also investigates how PTPN2 shapes the intestinal microbiome, to modify host-bacterial interactions in the gut. He currently serves as co-Chair of a research grant review committee of the Crohn’s and Colitis Foundation, and is a chartered member of the NIH DHMI study section. He has received a number of awards including the New Investigator Award from the GI & Liver Section of the American Physiological Society in 2011. In 2017 he received a “Top 50 in 50” award in recognition as one of the top 50 contributors in the past 50 years to furthering the mission of the Crohn’s and Colitis Foundation, San Diego and Desert Area Chapter. At UCR, he serves as Chair of the SOM Faculty Executive Committee, and directs medical school teaching of GI Physiology & Pharmacology.


Dr. McCole is the recipient of research funding awards from Pfizer Inc. (unrelated to manuscript/commentary)